Comparison of 18F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL® approaches: Validation against histopathology. Issue 6 (14th May 2019)
- Record Type:
- Journal Article
- Title:
- Comparison of 18F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL® approaches: Validation against histopathology. Issue 6 (14th May 2019)
- Main Title:
- Comparison of 18F‐florbetaben quantification results using the standard Centiloid, MR‐based, and MR‐less CapAIBL® approaches: Validation against histopathology
- Authors:
- Doré, Vincent
Bullich, Santiago
Rowe, Christopher C.
Bourgeat, Pierrick
Konate, Salamata
Sabri, Osama
Stephens, Andrew W.
Barthel, Henryk
Fripp, Jurgen
Masters, Colin L.
Dinkelborg, Ludger
Salvado, Olivier
Villemagne, Victor L.
De Santi, Susan - Abstract:
- Abstract: Introduction: 18 F‐florbetaben is currently approved for the visual rule out of β‐amyloid (Aβ) pathology. It is also used for recruitment and as an outcome measure in therapeutic trials, requiring accurate and reproducible quantification of Aβ burden in the brain. Methods: Data from eighty‐eight subjects (52 male subjects, aged 79.8 ± 10.6 years) who underwent antemortem 18 F‐florbetaben positron emission tomography scan and magnetic resonance imaging less than a year before neuropathological assessment at autopsy were evaluated. Image analysis was performed using the standard Centiloid (CL) statistical parametric mapping approach and CapAIBL ® . Imaging results were compared against autopsy data. Results: Against combined Bielschowsky silver staining and immunohistochemistry histopathological scores, statistical parametric mapping had 96% sensitivity, 96% specificity, and 95% accuracy, whereas magnetic resonance–less CapAIBL standardized uptake value ratioWhole Cerebellum had 94% sensitivity, 96% specificity, and 95% accuracy. Based on the combined histopathological scores, a CL threshold band of 19 ± 7 CL was determined. Discussion: Quantification of 18 F‐florbetaben positron emission tomography scans using magnetic resonance–based and magnetic resonance–less CapAIBL ® approaches showed high agreement, establishing a pathology‐based threshold in CL.
- Is Part Of:
- Alzheimer's & dementia. Volume 15:Issue 6(2019)
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 15:Issue 6(2019)
- Issue Display:
- Volume 15, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 15
- Issue:
- 6
- Issue Sort Value:
- 2019-0015-0006-0000
- Page Start:
- 807
- Page End:
- 816
- Publication Date:
- 2019-05-14
- Subjects:
- Alzheimer's disease -- Dementia -- β‐amyloid -- Positron emission tomography (PET) -- Florbetaben -- Histopathology -- Centiloid
Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jalz.2019.02.005 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13271.xml